Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis.
Violante Di DonatoGiuseppe CarusoMarco PetrilloEvangelos KontopantelisInnocenza PalaiaGiorgia PerniolaFrancesco PlottiRoberto AngioliLudovico MuziiPierluigi Benedetti PaniciGiorgio BoganiPublished in: Vaccines (2021)
HPV vaccination, in adjuvant setting, is associated with a reduced risk of recurrent CIN 1+ and CIN 2+ after surgical treatment.